European Society of Cardiology (ESC)

This page includes news from the European Society of Cardiology (ESC). The ESC represents more than 95,000 men and women in the field of cardiology from Europe, the Mediterranean basin. It is the European umbrella cardiology organization, which includes the European Association of Percutaneous Cardiovascular Interventions (EAPCI), which hosts the large EuroPCR meeting; the European Heart Rhythm Society (EHRA); European Association of Cardiovascular Imaging (EACVI); European Association of Preventive Cardiology (EAPC); and the Association for Acute Cardiovascular Care (ACVC).

Thumbnail

Empagliflozin reduces risk of cardiovascular death, hospitalization among heart failure patients

The EMPEROR-Reduced trial included data from more than 3,700 adult patients with HF and a left ventricular ejection fraction of 40% or less.

Thumbnail

How to predict a CVD patient’s risk of total, colorectal and lung cancer

The analysis was presented at ESC Congress 2020 and published in JACC: CardioOncology.

Thumbnail

Burnout in cardiology: Most pediatric heart nurses feel exhausted, with 30% eyeing a career change

Nurses are unhappy with their working conditions, which leads to stress and exhaustion. 

Thumbnail

More cardiology conferences canceled over COVID-19 concerns

Healthcare conferences all over the world have been delayed or canceled due to the COVID-19 pandemic, and two more significant cancellations have been announced that impact cardiology professionals.

Thumbnail

Tafamidis shows promise for treating cardiac amyloidosis

Research presented this week at the European Society of Cardiology Congress in Munich suggests a new treatment may be emerging for transthyretin amyloid cardiomyopathy—a condition previously thought to be rare and untreatable.